INTRODUCTION
Tetracyclines (TCs) are polyketide natural products, which include a number of clinically important antibacterials, such as TC, oxytetracycline (5-hydroxy-TC, OTC) (Fig. 1a) and chlortetracycline (7-chloro-TC, CTC). Second and third generation semi-synthetic derivatives, such as minocycline and doxycycline, were introduced to the clinic to combat antibiotic resistance. Most recently, tigecycline (9-glycyl-glycyl OTC) was introduced, which is the first clinical example of a TC that has a functional group on the C-9 of the D ring (Petersen et al., 1999) . All these TCs have the typical carboxamido group at C-2 (Fig. 1a) , which is thought to be incorporated as the nascent tetracycline precursor chain is initiated (Petković et al., 2006) . TCs were the first major class of therapeutics to earn the distinction of 'broad-spectrum antibiotic' . Their mode of action is to bind to the elongating ribosome and inhibit translation (Wilson, 2009 ).
Chelocardin (CHD) (Fig. 1b) is an atypical TC that is not an inhibitor of translation (Chopra, 1994) . CHD is produced by the rare actinobacterium Amycolatopsis sulphurea (Lechevalier et al., 1986) , and displays potent broad-spectrum antibacterial activity. It is highly active against both Gram-positive (including Staphylococcus aureus) and Gram-negative bacteria; it also has potent activity against most multi-resistant pathogens, including some difficult-to-treat Gram-negative organisms (Oliver & Sinclair, 1964; Proctor et al., 1978) . In contrast to the bacteriostatic activity of 'typical' clinical TCs, CHD is bacteriolytic, although its mechanism of action has yet to be elucidated .
Compared to typical TCs, CHD has unusual structural features (Fig. 1b) . This natural product has an acetyl rather than a carboxamido moiety at C-2 (Fig. 1b) , a different aromatization pattern at ring C and is functionalized at C-9. It also has fewer functional groups that are added after completion of the polyketide backbone. CHD has a different mode of action from TCs and is effective against TC-resistant bacteria (Chopra, 1994) . Consequently CHD represents a new scaffold for the engineering of novel tetracyclic antibacterials through synthetic biology. These could be further derivatized through semi-synthetic efforts to develop novel compounds active against multi-resistant pathogen strains. As a result, it was our aim to clone and analyse the gene cluster encoding CHD biosynthesis from A. sulphurea, and to explore the basic biosynthetic mechanisms involved in the formation of this atypical TC.
METHODS
Bacterial strains and culture conditions. Amycolatopsis sulphurea NRRL2822 was used for CHD production and as a source of DNA for preparation of DNA libraries. Escherichia coli DH10B was used for standard cloning procedures (Sambrook & Russell, 2001 ). E. coli ET12567 (MacNeil et al., 1992) was used to produce non-methylated plasmid DNA, suitable for transformation of A. sulphurea. E. coli XL1-Blue MR (Stratagene) was used as a host for cosmid libraries. See Table 1 for more details. Soya mannitol (MS) agar and tryptone soy broth (TSB) (Kieser et al., 2000) were used for generating spores and cultivation of A. sulphurea at 30 uC in liquid medium respectively. For CHD production, A. sulphurea was cultivated in CH-V seed medium (1.5 % soy flour, 0.1 % yeast extract, 1.5 % glucose, 0.5 % NaCl, 0.1 % CaCO 3 , pH 7.0) and CH-F2 production medium (2 % soy flour, 0.5 % yeast extract, 0.2 % CaCO 3 , 0.05 % citric acid, 5 % glucose, pH 7.0) (adapted from Oliver & Sinclair, 1964; Mitscher et al., 1983) . Cultivation was carried out in 250 ml Erlenmeyer flasks, containing 40 ml of medium or in 50 ml Falcon tubes, containing 5 ml of medium. Seed cultures were cultivated in CH-V at 30 uC on a rotary shaker at 220 r.p.m. and 2 inch (5.1 cm) throw for 36 h. 15 % (v/v) of seed culture was used to inoculate CH-F2 production medium and cultivated for a further 7 days under the same conditions. For transformation of A. sulphurea, S27M and R2L media were used (Madoń & Hutter, 1991) . See Table 1 for more details. Apramycin (Apr; 400 mg ml 21 ) and erythromycin (Erm, 20 mg ml 21 ) in MS were used for selection of A. sulphurea transformants. For selection of E. coli strains, ampicillin (Amp), apramycin (Apr), kanamycin (Kan) and chloramphenicol (Cm) were added into 26YT (16 g tryptone l
21
, 10 g yeast extract l 21 , 5 g NaCl l 21 ; pH 7.2) at concentrations of 100, 50, 25 and 10 mg ml 21 , respectively.
DNA isolation and manipulation. Isolation and manipulation of DNA in E. coli were carried out according to standard protocols (Kieser et al., 2000; Sambrook & Russell, 2001) . Transformation of A. sulphurea NRRL2822 was carried out by the protocol for transformation of Amycolatopsis mediterranei, using vectors pAB03 and pNV18 (Chiba et al., 2007; Madoń & Hutter, 1991) . Southern and colony hybridizations were carried out with a DIG High Prime DNA Labelling and Detection Starter kit I (Roche Diagnostics) according to standard protocols (Medveczky et al., 1987; Olszewska & Jones, 1988; Sambrook & Russell, 2001 ).
Preparation of a shotgun and cosmid library of A. sulphurea.
The ketosynthase a (KSa) DNA sequence probe was amplified by PCR from A. sulphurea genomic DNA using degenerate primers PKSF and PKSR (Table S1 , available in Microbiology Online) based on universally conserved motifs of type II acyl-KSa (Metsä-Ketelä et al., 1999) . This probe was hybridized against restriction digests of A. sulphurea genomic DNA with various enzymes. An 8 kb EcoRI fragment that gave a positive result after Southern hybridization with a DIG-labelled KSa PCR probe was the most suitable for generating a shotgun library in pUC19. Genomic DNA was digested with EcoRI and the resulting DNA fragments were separated on an agarose gel. 8 kb DNA fragments were extracted from the agarose gel and cloned into the A cosmid library of A. sulphurea genomic DNA was prepared using partial digests with Sau3AI (35-50 kb fragments) ligated to the integrative conjugative cosmid vector pLUS02 (Petkovic et al., 2013) , a modified version of the commercial SuperCos1 vector (Stratagene), containing sequences which enable conjugative transfer and integration into Streptomyces genomes containing oriT, attP and int by ligating a 3.7 kb PvuII-BamHI fragment from pQ803 (Bierman et al., 1992) . The ligated DNA was packaged into phage particles (Gigapack III Gold Packaging kit, Stratagene) and introduced into XL1-Blue MR E. coli cells.
Identification and sequencing of chelocardin gene cluster. The cosmid library (1600 colonies) was screened by colony hybridization using the partial KSa probe. Eighteen positive clones were selected and additional PCR screening was carried out using the primers PKSF, PKSR, C-MTF, C-MTR, CobdoF and CobdoR (Table S1 ), which were designed on the basis of the previously obtained DNA sequence of pLUC10E. Based on the PCR screen and end-sequencing of the cosmids, pLUS02VIIC4 cosmid was selected for complete sequencing (Macrogen) . Putative open reading frames (ORFs) were determined using FramePlot beta 4.0. (http://nocardia.nih.go.jp/fp4/). The putative gene functions were determined manually using BLASTP, available online at NCBI (http://www.ncbi.nlm.nih.gov/blast/).
Inactivation of the minimal polyketide synthase (PKS) of the chd gene cluster. The putative chd gene cluster was disrupted in the chromosome of A. sulphurea by allelic replacement through a doublecrossover event. Plasmid pNV18chdPKSErm was constructed by cloning ermE (Uchiyama & Weisblum, 1985) , flanked by~1 kb of DNA homologous to the putative minimal PKS on either side of the resistance gene. The left arm was amplified by PCR using primers 8 kb-LHindIII-F and 8 kb-LEcoRI-R (Table S1 ) and later digested with HindIII and EcoRI to obtain the 1005 bp fragment (Fig. S1) . Similarly, the right arm of homology was amplified by PCR using primers 8 kb-DXbaI-F and 8 kb-DBamHI-R (Table S1) , and later digested with XbaI and BamHI to obtain the right arm 1049 bp fragment. These three DNA fragments were then ligated into pNV18 containing a kanamycin resistance marker to obtain pNV18chdPKSErm, resulting in a plasmid construct containing the chd minimal PKS cluster disrupted with ermE ( Fig. S1 ). E. coli ET12567 (MacNeil et al., 1992) was transformed with pNV18chdPKSErm and the plasmid introduced into the wild-type strain of A. sulphurea via direct transformation of mycelium (Madoń & Hutter, 1991) . Plates were overlaid with erythromycin after overnight incubation. Each transformant colony was further repatched to MS agar containing erythromycin and subcultured three times. After two subcultivations on MS plates, erythromycinresistant/kanamycin-sensitive (Erm R /Kan S ) colonies (secondary recombinants) were isolated and the double-crossover confirmed by Southern hybridization with EcoRI-digested genomic DNA, using a chd PKS probe [PCR-amplified by chdPF and chdSR primers (Table S1) ].
HPLC analysis of chelocardin production. Broths of wild-type and recombinant A. sulphurea strains were acidified to pH 1-2 with 50 % trifluoroacetic acid, followed by extraction with an equal volume of 1-butanol. The upper organic extract was separated by centrifugation and analysed. HPLC was performed using a Thermo Finnigan Surveyor, with a Machery Nagel Nucleodur 15064.6 mm column with 3 mm particles. The auto-sampler was equipped with a 10 ml loop, and the column oven temperature was 40 uC, whereas the vial tray was left at room temperature. The PDA detector was operated in scanning mode from 190 to 360 nm; the optimal wavelength for Isolation of CHD. CHD was isolated from A. sulphurea broths using Strata-X polymeric SPE (solid-phase extraction) columns, filled with Polymeric Reversed Phase sorbent. SPE protocol: After acidification of broths with trichloroacetic acid, CHD was extracted with dichloromethane. The extracts were evaporated and dissolved in methanol. They were diluted with 10 % (v/v) methanol, acidified with formic acid and loaded on the SPE column. Elution was achieved with increasing concentrations of methanol and fractions were analysed for content and purity by HPLC, as described above. HCl (37 %) was added to the appropriate SPE fraction and methanol was evaporated. After incubation at 4 uC for 48 h, a precipitate of CHD appeared, which was dried, washed with hexane and used later for NMR analysis. 
RESULTS AND DISCUSSION
Isolation of CHD and its structural confirmation CHD was isolated using SPE columns as described in Methods. After assessment of the purity of the isolated compound by HPLC, its structure was confirmed by HRMS, 1 H and 13 C NMR experiments (NMR experiments were repeated at least three times; each time 5 mg of the isolated compound was used). The HRMS mass for C 22 , which allows direct comparison of our data and therefore structure confirmation (Mitscher et al., 1970) . That spectrum is poorly resolved, namely the key protons 5-H9, 5-H99 and 4a-H are given as a multiplet at 2.5-3.8 p.p.m. Therefore, the assignments of all proton signals in the 1 H NMR spectra of CHD reported here (Table S2) were made by comparison of our data with other analogous systems, such as N-acetyl-CHD (Mitscher et al., 1970) . Highresolution NMR spectroscopy, with determination of coupling constants for protons attached to C-4, C-4a and C-5, not only confirms the structure of CHD but also provides evidence for the stereochemistry at C-4 and therefore establishment of the conformation of the molecule in the DMSO-d 6 solution (Fig. S2) . The small value of the J 4a-H, 4-H coupling constant suggests a dihedral angle of ca 606 and supports the geometry of the molecule as shown in Fig. 1(b) . In the 13 C NMR spectrum of CHD at 75 MHz, only 21 signals are seen, as shown in Fig. S3 , although the number of carbon atoms in the molecule is 22. To the best of our knowledge, there is only one report on 13 C NMR chemical shifts of CHD, where only five resonances are listed (Chu et al., 1981) . Our data are in agreement with this report. On the basis of 13 C NMR, we predict that the missing signal corresponds to the bridged 4a-C, which should appear around 40 p.p.m., where DMSO-d 6 resonates (Table S2) . Since the concentration of the NMR sample was low (less than 5 mg ml 21 of CHD in DMSO-d 6 ) the absence of one signal could be explained by masking by the DMSO peak. Taken together, the signals in the 13 C NMR spectrum of CHD corroborate its structure and confirm the identity of the isolated compound.
Identification and characterization of the chd biosynthetic gene cluster (Hertweck et al., 2007) . Using a KSa probe (PKSF-PKSR, Table S1 ; Methods), a genomic fragment containing the putative minimal PKS of the chd gene cluster was cloned, characterized and validated, and used to identify a larger overlapping clone from an A. sulphurea cosmid library which was subsequently sequenced (Methods). The chd biosynthetic gene cluster spans over 20 kb of DNA and contains 18 putative ORFs (Fig. 2) .
A gene disruption/replacement approach was carried out in order to establish that the cloned DNA segment encoded the biosynthesis of CHD (Methods). The Amycolatopsis strains have often proven difficult to transform and genetically manipulate (Malhotra & Lal, 2007; Dhingra et al., 2003) . We have invested very significant efforts to develop a transformation procedure for A. sulphurea, where we tested various growth media, numerous actinomycete plasmids (replicative and integrative) in combination with different procedures, such as protoplast transformation and E. coli-A. sulphurea conjugation. Finally, using the Nocardia sp. replicative plasmid pNV18 in combination with the transformation procedure developed for A. mediterranei (Chiba et al., 2007; Madoń & Hutter, 1991) , a successful procedure was discovered (data not shown). It was also important to identify suitable promoters and resistance markers, as described in Methods.
Analysis of six independent transformants that had the Erm R /Kan S phenotype was indicative of chdPKS deletion and replacement with Erm R via a double recombination event. Southern blotting was used to confirm the allelic replacement (Fig. S4) . Inactivation of CHD biosynthesis in disrupted Erm R /Kan S colonies was confirmed by HPLC and LC/MS (Fig. 3 and Fig. S5) . Complementation of the Erm R /Kan S recombinants in trans, using either pAB03 : 8 kb (containing the entire 8 kb EcoRI fragment encoding the minimal PKS transcribed from its native promoter) or pAB03chdPKS (containing the minimal chdPKS genes under the control of the actII-ORF4/PactI activator/promoter system) (Fig. S1 ) restored production of CHD, as shown by HPLC (Fig. 3) and confirmed by LC/MS. Higher yields of CHD were obtained with the pAB03 : 8 kb plasmid (160 mg l
21
) when compared to complementation with pAB03chdPKS (80 mg l
) suggesting stronger expression of the minimal PKS from its native promoter (Fig. 3) . CHD production in the wild-type strain was around 1 g l
.
Annotation and bioinformatic analysis of the chd gene cluster Type II polyketide gene clusters share many common features (Table 2, Fig. 2) . Consistent with the chemical structure of CHD and the strategy employed to clone the chd cluster, chdP, chdK and chdS form the minimal type II PKS: KSa, KSb and ACP, respectively and catalyse synthesis of nascent polyketide backbone. It is believed that initiation of biosynthesis in the reiterative type II PKS systems, such as CHD, is acetate primed through decarboxylation of CoA activated malonate (Moore & Hertweck, 2002) . At least in actinorhodin (Carreras & Khosla, 1998; Hitchman et al., 1998) and tetracenomycin (Bao et al., 1998) biosynthesis, malonyl-CoA rather than acetyl-CoA is the proximate primer of the PKS. It is assumed that most type II PKSs are primed by decarboxylation a malonyl unit to yield an acetyl-S-KS intermediate that is subsequently elongated by the minimal PKS. Bisang et al. (1999) demonstrated that the KSb (CLF) has decarboxylase activity towards malonylCoA, in close analogy to the KSQ of modular PKSs. The decarboxylation activity of KSb (KSQ), where a glutamine residue plays an important role, designated KSQ (Bisang et al., 1999) , is also present in the CHD gene cluster. Interestingly, CoA activated acetoacetate was proposed as the precursor of the 2-acetyl-2-decarboxyamidooxytetracycline (ADOTC) impurity in OTC biosynthesis (Fu et al., 1994) . Therefore, ChdL, which shares 56 % identity to OxyH from Streptomyces rimosus (Zhang et al., 2006) , which is putatively involved in the activation of the starter unit, could also have a role in priming steps of CHD biosynthesis. A conserved domain search shows that the ChdL gene product has two domains: an acyl-CoA ligase domain and a monooxygenase domain. ChdL has two conserved motifs: (a) (T/S)SG(T/S)(T/S)GXPKG, which is a phosphate-binding loop (P-loop), found in many ATPand GTP-binding proteins (Saraste et al., 1990) , and (b) CHD was quantified using a standard and calculated from the area under the curve.
TGD, identical to the C-terminal ATP-binding loops of ATPases (Taylor & Green, 1989) .
Cyclization and aromatization of the CHD backbone is likely carried out by a number or proteins. ChdT is a putative aromatic PKS ketoreductase involved in the expected region-specific reduction at C-8, when using the chemical nomenclature (Fig. 4) , which is initially a carbonyl group as the nascent polyketide chain is formed and then folds back on itself when C-8 is reduced. This position (C-8, Fig. 4 ) is often referred in the literature as the 'C-9 position' when counting of carbon atoms is carried out from the enzyme-bound side of the nascent polyketide backbone (Hopwood, 1997) . Typically, type II polyketide gene clusters encode a single two-component cyclase/aromatase gene product such as OxyK (Zhang et al., 2006 (Zhang et al., , 2007 , previously named OtcD1 (Petkovic et al., 1999) . Surprisingly, the chd cluster encodes two such homologues, ChdQI and ChdQII (Table 2) , both aligning with OxyK (32 % and 58 % identity, respectively (Fig. S6 ). (Ames et al., 2008) . This apparent duplication of function is unique; it is not present in any other type II polyketide gene clusters. The second CYC/ ARO homologue (ChdQI) may be needed for aromatization of ring C in CHD (Fig. 4) , whereas ring C is not aromatized in 'typical' clinical TCs (Figs 1a and 4) . The presence of adjacent aromatic rings (D and C) has a profound influence on the stereochemical properties of atypical TCs, such as CHD. Compared to the typical TCs (Fig. 1a) , which bind to the ribosome in a cleft into which TCs fit due to a 'kink' between rings A and B (Pioletti et al., 2001) , CHD forms a more planar molecule, and consequently should not bind to the ribosome. ChdQI, thus might have important evolutionary implications for the development of this group of 'atypical' TCs, including CHD, and hence derivation of compounds that can treat tetracycline-resistant infections. ChdX has 64 % identity to a monodomain cyclase, OxyI, from S. rimosus, whose putative function is in the formation of the final ring A in the biosynthesis of OTC (Lombó et al., 1996; Zhang et al., 2006) . Zhang et al. (2007) later suggested that the closure of the final ring A of OTC is spontaneous because of the presence of the terminal amino group (Zhang et al., 2007) . However, they proposed that monodomain cyclases are needed for closure of ring A of those polyketides that have acetate as a primer unit (such as daunorubicin and tetracenomycin); CHD falls into this category. Definitive proof of this function will come from gene disruption of chdX, or it may be that the A ring can fold spontaneously.
CHD differs from OTC and other typical TCs in having a methyl group at C-9, and no dimethylamino group at C-4 (Figs 1 and 4) , whereas C-6 is methylated in both CHD and typical TCs. Two putative methyltransferases (MT), ChdMI and ChdMII (Table 2) , are encoded by the cluster; the former sharing identity (66 %) with OxyF (MT) from S. rimosus, which methylates C-6 of pretetramid early in biosynthesis (Zhang et al., 2006) . We propose that ChdMI transfers a methyl group to the same position in CHD biosynthesis. The two putative chd methyltransferases, ChdMI and ChdMII, are SAM-dependent but otherwise have poor homology to each other. ChdMII shares identity (45 %) with CmmMII, a Cmethyltransferase from Streptomyces griseus subsp. griseus, acting at C-9 of the aromatic ring of chromomycin Fig. 4 . Proposed CHD biosynthetic pathway. C8, the target for region-specific reduction by ChdT, is highlighted by a dashed circle.
Identification of the chelocardin gene cluster (Menéndez et al., 2004) . It is therefore the preferred candidate for C-9-methylation. Expression of chdMII in hosts that make typical TCs will test whether such recombinants can make 9-methyl derivatives of typical TCs, opening up a new subfamily of TC-like compounds.
Methylation at C-6 occurs early in TC biosynthesis, as 6-methylpretetramid can be isolated (McCormick et al., 1968) from TC production media. Broths of A. sulphurea producing CHD had traces of a compound with a mass corresponding to desmethyl-CHD, as estimated by LC/MS (data not shown), thus supporting the hypothesis that 6-methylation occurs early in the biosynthesis of CHD.
ChdOIII is most likely a very short monooxygenase domain-containing protein, which, from the deduced DNA sequence, forms a fusion protein with the putative acyl-CoA ligase ChdL. This is a similar architecture to OxyG and OxyH from S. rimosus (Zhang et al., 2006) . A conserved domain search identified ChdOIII as an ABM (antibiotic biosynthesis monooxygenase) that does not contain an FAD (flavin adenine dinucleotide) binding site. ABMs do not have the prosthetic groups, metal ions or cofactors usually needed for activation of molecular oxygen. A possible involvement in the quinone formation of ring A in 4-keto-ATC or a potential auxiliary role of ChdOIII, OxyG homologue, such as that shown for ChdOI, OxyE homologue, was also proposed (Pickens & Tang, 2010; Zhang et al., 2006) . Hydroxylation at C-4 is a prerequisite for amino-group incorporation at C-4 in both CHD and typical TCs. In S. rimosus, OxyE is an ancillary mono-oxygenase for OxyL with a nonessential, but important role in improving its efficiency as a C-4
hydroxylase (Wang et al., 2009) . In contrast to OTC, CHD does not contain hydroxyl groups at C-5 and C-6 and differs in the pattern of reduction of carboxyl groups at C-11 and C-12, thus resulting in the less polar structure of CHD (Fig. 1b) . Based on bioinformatic analysis, ChdOI and ChdOII are likely involved in hydroxylation of C-4/ 12a, prior to transamination at C-4 (Fig. 4) T. Lukežič and others evolutionary origin. The C-4 amino group of CHD is epimeric to other typical TCs ( Fig. 1 ; Rasmussen et al., 1991) , which may be explained by the action of this species of aminotransferase. Orthogonal transfer of chdN to hosts making typical TCs might result in production of the 4-epi analogues.
A number of self-resistance and regulatory proteins are also encoded by the chd cluster. ChdR is a putative multidrug efflux resistance protein from the EmrB/QacA subfamily. Its closest homologue (62 % identity, Table 2 ) is a transporter from S. hygroscopicus subsp. jinggangensis 5008 located in an uncharacterized type II gene cluster (Wu et al., 2012) . This is the only 'resistance' mechanism in the chd cluster whereas, the otc and ctc clusters have an exporter of the major facilitator family (OtrB and Ctc05, respectively) for efflux (McMurry & Levy, 1998) and have a ribosomal factor (OtrA and Ctc14 respectively); the latter protects the ribosome from translational arrest by tetracyclines. This also provides circumstantial evidence for an atypical mode of action by chelocardin, although it is not possible to rule out the presence of alternative resistance factors encoded elsewhere in the A. sulphurea genome.
ChdA is most similar (60 %, Table 2 ) to a transcriptional regulator from S. hygroscopicus subsp. jinggangensis 5008 (Wu et al., 2012) belonging to the TetR family of proteins, which are involved in the transcriptional control of multidrug efflux pumps, pathways for the biosynthesis of antibiotics and differentiation processes.
There are also a number of other genes that are encoded by the cluster that may not be needed for CHD biosynthesis. They include two putative redundant ORFs (Table 2) within the chd cluster, chdGIV and chdTn, encoding a glycosyltransferase and a transposase respectively; these genes could represent an evolutionary legacy of horizontal transfer from a gene cluster of a glycosylated polyketide, such as chromomycin or mithramycin.
Conclusions
Compared to typical TCs such as OTC, the chemical structure of CHD contains a number of unusual characteristics such as planarity of the tetracyclic rings, hydrophobicity, substituent groups and starter moiety. Analysis of the chd biosynthetic gene cluster has allowed us to identify possible mechanisms by which these structural features are achieved. Collectively, these enzymes deliver a molecule with different aromatization of ring C that results in alteration of the planar structure of the TC backbone. This is a likely contributor to the different mode of action of chelocardin, which represents a unique opportunity for efficient generation of novel TC backbones using combinatorial biosynthesis. Using such a biosynthetic engineering approach, the chd gene cluster is an attractive system both to study TC biosynthesis and to produce further orthogonal derivatives, by either synthetic biology or semi-synthesis, which may have potential medical use.
